John D Grabenstein
Affiliation: Merck Research Laboratories
- Bioterrorism and compulsory vaccination: United States continues vaccinating to keep troops healthyJohn D Grabenstein
BMJ 329:977; author reply 977. 2004
- Vaccines: countering anthrax: vaccines and immunoglobulinsJohn D Grabenstein
Merck Vaccines and Infectious Diseases, West Point, Pennsylvania 19486 0004, USA
Clin Infect Dis 46:129-36. 2008..To treat anthrax infection, passive immunization using a polyclonal or monoclonal antibody product may offer important clinical benefit, especially if the anthrax bacteria are resistant to multiple antibiotics...
- Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adultsJohn D Grabenstein
Merck Vaccines, 770 Sumneytown Pike, WP97 B364, West Point, PA 19426, USA Electronic address
Vaccine 32:2399-405. 2014..To characterize differences in serious outcomes between pneumococcal serotypes, we systematically reviewed the literature...
- What the world's religions teach, applied to vaccines and immune globulinsJohn D Grabenstein
Merck Vaccines, 770 Sumneytown Pike, WP97 B364, West Point, PA 19426, USA
Vaccine 31:2011-23. 2013..Key considerations for observant believers for each populous religion are described...
- A century of pneumococcal vaccination research in humansJ D Grabenstein
Merck Vaccines, West Point, PA 19426, USA
Clin Microbiol Infect 18:15-24. 2012..Today, emergence of disease caused by pneumococcal serotypes not included in various vaccine formulations fuels research into conserved proteins or other means to maximize protection against more than 90 known pneumococcal serotypes...
- Immunization 1967-2006: implementation keeping pace with invention?John D Grabenstein
Merck Vaccine Division, WP97 A261, 770 Sumneytown Pike, West Point, PA 19486 0004, USA
Ann Pharmacother 41:119-20. 2007
- Advantages of standardizing vaccine and antibody nomenclatureJohn D Grabenstein
Scientific Affairs, Merck Vaccines and Infectious Diseases, West Point, PA, USA
J Am Pharm Assoc (2003) 48:105-7. 2008
- Daily versus single-day offering of influenza vaccine in community pharmaciesJohn D Grabenstein
School of Pharmacy, University of North Carolina, Chapel Hill, USA
J Am Pharm Assoc (2003) 49:628-31. 2009..To assess the cumulative number of influenza vaccinations delivered per pharmacy in relation to number of days of offering vaccination per season...
- Cost-effectiveness of stockpiling 23-valent pneumococcal polysaccharide vaccine to prevent secondary pneumococcal infections among a high-risk population in the United States during an influenza pandemicPraveen Dhankhar
Health Economic Statistics, Merck and Co, Inc, North Wales, Pennsylvania 19454, USA
Clin Ther 32:1501-16. 2010..Stockpiling a pneumococcal vaccine can ensure that it is available when needed most-that is, at the onset of a pandemic...
- Patient experience with, and use of, an electronic monitoring system to assess vaccination responsesStuart S Olmsted
Associate Natural Scientist, RAND Corporation, Pittsburgh, PA, USA
Health Expect 9:110-7. 2006..To evaluate the user experience and acceptability of an electronic patient monitoring system...
- Anthrax vaccine: a reviewJohn D Grabenstein
US Army Medical Command, 5111 Leesburg Pike, Falls Church, VA 22041, USA
Immunol Allergy Clin North Am 23:713-30. 2003..A comprehensive, peer-reviewed evaluation by the National Academy of Sciences affirmed the findings of multiple previous independent panels that found that the US-licensed anthrax vaccine is safe and effective...
- Assessing the safety of anthrax immunization in US Army aircrew members via physical examinationJill Downing
Boston University School of Public Health, Boston, MA, USA
J Occup Environ Med 49:1079-85. 2007..Anthrax in weaponized form is the bioterrorism agent of most concern. Questions raised about the safety of the anthrax vaccine can be addressed by comparing immunized and unimmunized people in population-based studies...
- Disability among U.S. Army personnel vaccinated against anthraxSandra I Sulsky
ENVIRON Health Sciences Institute, Amherst, Massachusetts 01004 2424, USA
J Occup Environ Med 46:1065-75. 2004..90 to 1.04. Latency assumptions did not affect results. Anthrax vaccination does not increase risk of disability. This finding may be partially the result of factors influencing selection for vaccination or vaccine tolerance...
- Analysis of adverse events after anthrax immunization in US Army medical personnelGlenn M Wasserman
Preventive Medicine Department, Tripler Army Medical Center, Honolulu, Hawaii, USA
J Occup Environ Med 45:222-33. 2003..Our findings suggest that AVA is relatively reactogenic but do not indicate serious adverse health effects due to immunization...
- How effectively can health care settings beyond the traditional medical home provide vaccines to adolescents?Stanley J Schaffer
Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
Pediatrics 121:S35-45. 2008..Our goal was to evaluate the capacity of various health care settings to supplement the activities of the traditional medical home by delivering vaccines to adolescents...
- Smallpox vaccination and ischemic coronary events in healthy adultsRobert E Eckart
Brooke Army Medical Center, Fort Sam Houston, TX, United States
Vaccine 25:8359-64. 2007..7 after adopting pre-vaccination cardiac screening (RR 1.4 [95% CI: 0.8-2.7]). Implementation of pre-vaccination cardiac risk factor screening was not associated with a reduction in cardiac events...
- Smallpox vaccines for biodefense: need and feasibilityAndrew W Artenstein
Department of Medicine, Brown University, Memorial Hospital of RI, 111 Brewster Street, Pawtucket, RI 02860, USA
Expert Rev Vaccines 7:1225-37. 2008..This article will review the history of smallpox vaccines, assess the status of newer-generation vaccines and examine the overall risk-versus-benefit profile of smallpox vaccination...
- The value of immunization for God's peopleJohn D Grabenstein
Natl Cathol Bioeth Q 6:433-42. 2006
- Pandemics, avian influenza A (H5N1), and a strategy for pharmacistsStephen M Ford
Military Vaccine Agency, United States Army Medical Command, Falls Church, Virginia 22041, USA
Pharmacotherapy 26:312-22. 2006..Advances in vaccine research, development, and production through the use of reverse-genetics systems represent the most effective technology to rapidly produce a pandemic influenza vaccine...
- Vaccines: worth paying for the value returnedJohn D Grabenstein
US Army Medical Command, Falls Church, VA 22041 3258, USA
Ann Pharmacother 36:1471-2. 2002
- US military smallpox vaccination program experienceJohn D Grabenstein
Military Vaccine Agency, US Army Medical Command, Falls Church, VA 22041, USA
JAMA 289:3278-82. 2003..The resumption of smallpox vaccinations raises important questions regarding implementation and safety...
- Myopericarditis following smallpox vaccination among vaccinia-naive US military personnelJeffrey S Halsell
The University of Virginia, Charlottesville, USA
JAMA 289:3283-9. 2003..Although many viruses have been reported to cause myopericarditis, it has been a rare or unrecognized event after vaccination with the currently used strain of vaccinia virus (New York City Board of Health)...
- Where medicine and religion intersectJohn D Grabenstein
Ann Pharmacother 37:1338-9. 2003
- Using a structured medical note for determining the safety profile of anthrax vaccine for US soldiers in KoreaKenneth Hoffman
Military and Veterans Health Coordinating Board, 20420 0002, Washington, DC 20420 0002, USA
Vaccine 21:4399-409. 2003..Female gender, prior vaccine-associated adverse events, and medication use were significantly related to higher reports of adverse events. All reported immediate consequences resolved...
- Smallpox vaccination and myopericarditis: a clinical reviewDimitri C Cassimatis
Walter Reed Army Medical Center, Washington, DC 20037, USA
J Am Coll Cardiol 43:1503-10. 2004....
- Unintended smallpox vaccination of HIV-1-infected individuals in the United States militarySybil A Tasker
Department of Infectious Diseases, National Naval Medical Center, Bethesda, Maryland 20889, USA
Clin Infect Dis 38:1320-2. 2004..13 copies/cm3 (range, 2.54-5.16 copies/cm3). All vaccinees (3 primary and 7 repeat) had a normal, robust reaction without complications. Smallpox vaccine was well-tolerated in this small series of HIV-1-infected military personnel...
- Ocular complications in the Department of Defense Smallpox Vaccination ProgramGary L Fillmore
Ophthalmology Service, Department of Surgery, Walter Reed Army Medical Center, Washington, DC 20307, USA
Ophthalmology 111:2086-93. 2004..The purpose of this case series was to present an overview of the nature and frequency of ocular complications in the Department of Defense (DoD) Smallpox Vaccination Program...
- Pregnancy discovered after smallpox vaccination: Is vaccinia immune globulin appropriate?Peter G Napolitano
Department OBGYN, Division of Maternal Fetal Medicine, Madigan Army Medical Center, Tacoma, WA 98431, USA
Am J Obstet Gynecol 191:1863-7. 2004..We review the existing medical literature to access the risks of fetal vaccinia in these pregnancies and the controversy regarding the prophylactic use of vaccinia immune globulin...
- Comparison of clinical presentation of acute myocarditis following smallpox vaccination to acute coronary syndromes in patients <40 years of ageRobert E Eckart
Brooke Army Medical Center, Fort Sam Houston, Texas, USA
Am J Cardiol 95:1252-5. 2005..There was a trend toward earlier elevation of troponin-I and creatine kinase in patients with myocarditis compared with ACS...
- Public and patient concerns in catastrophic circumstancesJohn D Grabenstein
Anthrax Vaccine Immunization Program Agency, U S Army Medical Command, Falls Church, VA 22041, USA
Am J Health Syst Pharm 59:923-5. 2002